Prognostic significance of S-phase fraction as measured by DNA flow cytometry in gynecologic malignancies.
Strang
P
P
Department of Oncology, Uppsala University, Akademiska Sjukhuset, Sweden.
Stendahl
U
U
Tribukait
B
B
D000230:Adenocarcinoma / Q000235:genetics / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000473:pathology; D004273:DNA, Neoplasm / Q000032:analysis*; D016889:Endometrial Neoplasms / Q000235:genetics / Q000473:pathology; D005260:Female; D005434:Flow Cytometry / Q000379:methods*; D005833:Genital Neoplasms, Female / Q000235:genetics* / Q000473:pathology*; D006801:Humans; D008875:Middle Aged; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000235:genetics / Q000473:pathology; D011003:Ploidies; D011379:Prognosis; D016016:Proportional Hazards Models; D011446:Prospective Studies; D016196:S Phase; D002583:Uterine Cervical Neoplasms / Q000235:genetics / Q000473:pathology
D004273:DNA, Neoplasm